A new study published in JAMA Network Open highlights growing public health concerns over prescription drug promotion by social media influencers.
The International Council for Harmonization outlines a roadmap for future global standards on advanced drug manufacturing, highlighting gaps in current regulatory frameworks and calling for new guidelines to support emerging technologies.
A new study published in JAMA Network Open highlights growing public health concerns over prescription drug promotion by social media influencers.
The International Council for Harmonization outlines a roadmap for future global standards on advanced drug manufacturing, highlighting gaps in current regulatory frameworks and calling for new guidelines to support emerging technologies.
FDA requires an updated safety warning for Parkinson’s drug products containing carbidopa/levodopa due to their potential to cause vitamin B6 deficiency and seizures.
A legal update from Wilson Sonsini Goodrich & Rosati addresses FDA’s release earlier this month of a draft guidance clarifying the scope and eligibility criteria for new clinical investigation exclusivity.
